Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Treasury Shares (2020 - 2025)

Historic Treasury Shares for AdaptHealth (AHCO) over the last 4 years, with Q3 2025 value amounting to $25.5 million.

  • AdaptHealth's Treasury Shares changed 0.0% to $25.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $25.5 million for FY2024, which is 4095.27% down from last year.
  • Latest data reveals that AdaptHealth reported Treasury Shares of $2.9 million as of Q3 2025, which was up 0.12% from $2.9 million recorded in Q2 2025.
  • AdaptHealth's 5-year Treasury Shares high stood at $3.9 million for Q4 2023, and its period low was $199000.0 during Q2 2022.
  • Moreover, its 5-year median value for Treasury Shares was $2.4 million (2021), whereas its average is $2.4 million.
  • As far as peak fluctuations go, AdaptHealth's Treasury Shares soared by 58788.15% in 2023, and later plummeted by 4095.27% in 2024.
  • AdaptHealth's Treasury Shares (Quarter) stood at $14.0 million in 2022, then surged by 209.23% to $43.3 million in 2023, then plummeted by 40.95% to $25.5 million in 2024, then changed by 0.0% to $25.5 million in 2025.
  • Its Treasury Shares was $25.5 million in Q3 2025, compared to $25.5 million in Q2 2025 and $25.5 million in Q1 2025.